Article

Gene therapy trials for sickle cell disease halted after two patients develop cancer

2021-02-16

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd58a8a4-932e-541b-ae4f-f42d61524c58
DOI: 10.1126/science.abh1106

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gene therapy trials for sickle cell disease halted after two patients develop cancerDOI 10.1126/science.abh1106Read

Gene Therapy: A New Hope in Sickle Cell Disease TreatmentSemantic proximity Read

Gene therapy for sickle cell disease: An updateSemantic proximity Read

A new frontier: FDA approvals for gene therapy in sickle cell diseaseSemantic proximity Read

Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapySemantic proximity Read

Gene therapy for sickle cell disease: where we are now?Semantic proximity Read

Gene Therapy in a Patient with Sickle Cell DiseaseSemantic proximity Read

Genetic therapies for sickle cell diseaseSemantic proximity Read

Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challengesSemantic proximity Read

Sickle Cell Trait—Neglected Opportunities in the Era of Genomic MedicineSemantic proximity Read

Gene editing for sickle cell disease and transfusion dependent thalassemias- A cure within reachSemantic proximity Read

First CRISPR clinical trial gets green light from US panelSemantic proximity Read

Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell diseaseSemantic proximity Read